Marker Therapeutics, Inc. (MRKR)
1.23
-0.02
(-1.60%)
USD |
NASDAQ |
Sep 03, 14:10
Marker Therapeutics Cash and Short Term Investments (Quarterly) : 11.92M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.92M |
| March 31, 2026 | 15.64M |
| December 31, 2025 | 17.04M |
| September 30, 2025 | 18.94M |
| June 30, 2025 | 11.81M |
| March 31, 2025 | 13.69M |
| December 31, 2024 | 19.19M |
| September 30, 2024 | 9.000M |
| June 30, 2024 | 7.800M |
| March 31, 2024 | 11.32M |
| December 31, 2023 | 15.11M |
| September 30, 2023 | 17.47M |
| June 30, 2023 | 18.12M |
| March 31, 2023 | 6.401M |
| December 31, 2022 | 11.78M |
| September 30, 2022 | 18.08M |
| June 30, 2022 | 25.82M |
| March 31, 2022 | 28.82M |
| December 31, 2021 | 43.50M |
| September 30, 2021 | 48.71M |
| June 30, 2021 | 57.22M |
| March 31, 2021 | 64.51M |
| December 31, 2020 | 21.35M |
| September 30, 2020 | 26.96M |
| June 30, 2020 | 32.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 40.26M |
| December 31, 2019 | 43.90M |
| September 30, 2019 | 48.48M |
| June 30, 2019 | 53.44M |
| March 31, 2019 | 57.71M |
| December 31, 2018 | 61.75M |
| September 30, 2018 | 4.294M |
| June 30, 2018 | 7.783M |
| March 31, 2018 | 2.801M |
| December 31, 2017 | 5.129M |
| September 30, 2017 | 7.608M |
| June 30, 2017 | 9.963M |
| March 31, 2017 | 5.928M |
| December 31, 2016 | 7.851M |
| September 30, 2016 | 9.587M |
| June 30, 2016 | 3.768M |
| March 31, 2016 | 5.722M |
| December 31, 2015 | 6.577M |
| September 30, 2015 | 6.087M |
| June 30, 2015 | 3.105M |
| March 31, 2015 | 1.454M |
| December 31, 2014 | 0.1419M |
| September 30, 2014 | 0.6136M |
| June 30, 2014 | 0.0206M |
| March 31, 2014 | 0.0936M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 845.63M |
| Ironwood Pharmaceuticals, Inc. | 79.13M |
| SELLAS Life Sciences Group, Inc. | 138.44M |
| Rezolute, Inc. | 120.27M |
| ADMA Biologics, Inc. | 136.02M |